Startups
VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. The VisOne implantable system delivers Asymptomatic Diaphragmatic Stimulation (ADS) which generates transient intrathoracic pulses gaited to cardiac activity and augments cardiac hemodynamics.
Overview
Location
United States, Oregon, Beaverton
Employees
11-50
Total raised
$12.5M
Founded date
2015
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 4, 2025 | ACC.25 Panel of Experts Awards VisCardia Top Honors for Innovation in MedTech | VisCardia wins ACC.25 Innovation Pitch Competition Award PORTLAND, OR, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- VisCardia, Inc. is honored to announce that our team has won the judge’s vote during the Future Hub ACC.25 Innovation ... |
| Jul 30, 2024 | VisCardia Receives US FDA IDE Approval to Start the RECOVER HF Clinical Study | Breakthrough Device Therapy for Symptomatic Heart Failure PORTLAND, OREGON, UNITED STATES, July 30, 2024 /EINPresswire.com/ -- VisCardia, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of an Investigational Device... |
| Feb 3, 2017 | VisCardia Completes $12.5M Series B Financing | VisCardia, Inc., a Portland, Oregon-based medical device company developing a novel chronic heart failure therapy, completed series B financing. It simultaneously obtained assets and technology rights from Inovise Medical, Inc., with a comb... |
| Feb 2, 2017 | Term Sheet — Thursday, February 2 | ET CETERA Hello from the Upfront Ventures conference in Los Angeles, where, aside from sushi, all anyone can talk about is politics. A few notes on that: Paid Content What you need to know about growing cyberattacks From ExtraHop Just look ... |
| VisCardia | “VisCardia Inc., a privately held medical device developer in Portland Oregon, is developing a new implantable device therapy for heart failure.” |
Reviews 0
FAQ about VisCardia
When was VisCardia founded?
VisCardia was founded in 2015.
How much funding has VisCardia raised?
VisCardia has raised $12.5M in total across 1 funding round.
What has the press written about VisCardia?
Parsers VC has collected 6 articles mentioning VisCardia, among them “ACC.25 Panel of Experts Awards VisCardia Top Honors for Innovation in MedTech” (Apr 4, 2025) and “VisCardia Receives US FDA IDE Approval to Start the RECOVER HF Clinical Study” (Jul 30, 2024).
Is VisCardia still active?
Yes, VisCardia is active; its latest activity on Parsers VC dates from May 21, 2025.